{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:32:16Z","timestamp":1784287936498,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05012-x","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:05:21Z","timestamp":1777291521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hyperuricemia accelerates renal dysfunction due to hypertensive nephrosclerosis: the TAMA MED Project-CKD"],"prefix":"10.1186","volume":"27","author":[{"given":"Tomohiro","family":"Kaneko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitaro","family":"Kodani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Sugino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Shibasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harufumi","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Sasabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Iwabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"10","key":"5012_CR1","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1093\/ndt\/14.10.2271","volume":"14","author":"RG Luke","year":"1999","unstructured":"Luke RG. Hypertensive nephrosclerosis: pathogenesis and prevalence. Essential hypertension is an important cause of end-stage renal disease. Nephrol Dial Transpl. 1999;14(10):2271\u20138.","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"5012_CR2","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","volume":"41","author":"RJ Johnson","year":"2003","unstructured":"Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41(6):1183\u201390.","journal-title":"Hypertension"},{"issue":"16","key":"5012_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12882-015-0033-5","volume":"27","author":"V Kurra","year":"2015","unstructured":"Kurra V, Vehmas T, Er\u00e4ranta A, Jokihaara J, Pirttiniemi P, Ruskoaho H, et al. Effects of oxonic acid-induced hyperuricemia on mesenteric artery tone and cardiac load in experimental renal insufficiency. BMC Nephrol. 2015;27(16):35.","journal-title":"BMC Nephrol"},{"issue":"5","key":"5012_CR4","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/ki.2014.385","volume":"87","author":"F Preitner","year":"2015","unstructured":"Preitner F, Pimentel A, Metref S, Berthonneche C, Sarre A, Moret C, et al. No development of hypertension in the hyperuricemic liver-Glut9 knockout mouse. Kidney Int. 2015;87(5):940\u20137.","journal-title":"Kidney Int"},{"issue":"2","key":"5012_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.14740\/jocmr4085","volume":"12","author":"T Kaneko","year":"2020","unstructured":"Kaneko T, Kodani E, Fujii H, Nakamura H, Sasabe H, Tamura Y, et al. Medical and Dental Visits of Chronic Kidney Disease-Diagnosed Participants Analyzed From the Specific Health Checkups Results in Japan: TAMA MED Project-CKD. J Clin Med Res. 2020;12(2):115\u201321.","journal-title":"J Clin Med Res"},{"issue":"10","key":"5012_CR6","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1093\/ckj\/sfab014","volume":"14","author":"T Kaneko","year":"2021","unstructured":"Kaneko T, Kodani E, Fujii H, Asai R, Seki M, Nakazato R, et al. Anemia and atrial fibrillation as independent risk factors for new-onset chronic kidney disease: the TAMA-MED Project-CKD and AF. Clin Kidney J. 2021;14(10):2221\u20136.","journal-title":"Clin Kidney J"},{"issue":"10","key":"5012_CR7","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1007\/s10157-024-02507-5","volume":"28","author":"T Kaneko","year":"2024","unstructured":"Kaneko T, Kodani E, Fujii H, Nakamura H, Sasabe H, Tamura Y. High body mass index and triglyceride levels at health checkups increase the risk of new-onset chronic kidney disease and worsening renal function: the TAMA MED Project-CKD. Clin Exp Nephrol. 2024;28(10):1016\u201326.","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"5012_CR8","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1253\/circj.CJ-18-1038","volume":"83","author":"E Kodani","year":"2019","unstructured":"Kodani E, Kaneko T, Fujii H, Nakamura H, Sasabe H, Tamura Y, et al. Prevalence and Incidence of Atrial Fibrillation in the General Population Based on National Health Insurance Special Health Checkups - TAMA MED Project-AF. Circ J. 2019;83(3):524\u201331.","journal-title":"Circ J"},{"issue":"12","key":"5012_CR9","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1253\/circj.CJ-66-0187","volume":"84","author":"E Kodani","year":"2020","unstructured":"Kodani E, Kaneko T, Fujii H, Nakamura H, Sasabe H, Tamura Y, et al. Impact of Chronic Kidney Disease Classification on New-Onset Atrial Fibrillation in the General Population- The TAMA MED Project-AF and CKD. Circ J. 2020;84(12):2325.","journal-title":"Circ J"},{"issue":"12","key":"5012_CR10","doi-asserted-by":"publisher","first-page":"e061613","DOI":"10.1136\/bmjopen-2022-061613","volume":"12","author":"H Fujii","year":"2022","unstructured":"Fujii H, Kodani E, Kaneko T, Nakamura H, Sasabe H, Tamura Y. Sarcopenia and coexistent risk factors detected using the \u2018Yubi-wakka\u2019 (finger-ring) test in adults aged over 65 years in the public annual health check-up in Tama City, Tokyo: a cross-sectional study. BMJ Open. 2022;12(12):e061613.","journal-title":"BMJ Open"},{"issue":"6","key":"5012_CR11","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982\u201392.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"5012_CR12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/ki.1997.29","volume":"51","author":"A Fogo","year":"1997","unstructured":"Fogo A, Breyer JA, Smith MC, Cleveland WH, Agodoa L, Kirk KA, et al. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators. Kidney Int. 1997;51(1):244\u201352.","journal-title":"Kidney Int"},{"issue":"11","key":"5012_CR13","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.2215\/CJN.02560314","volume":"9","author":"HE Elsherbiny","year":"2014","unstructured":"Elsherbiny HE, Alexander MP, Kremers WK, Park WD, Poggio ED, Prieto M, et al. Nephron hypertrophy and glomerulosclerosis and their association with kidney function and risk factors among living kidney donors. Clin J Am Soc Nephrol. 2014;9(11):1892\u2013902.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"5012_CR14","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/s10157-015-1084-4","volume":"19","author":"T Yamamoto","year":"2015","unstructured":"Yamamoto T, Nakayama M, Miyazaki M, Matsushima M, Sato T, Taguma Y, et al. Relationship between low blood pressure and renal\/cardiovascular outcomes in Japanese patients with chronic kidney disease under nephrologist care: the Gonryo study. Clin Exp Nephrol. 2015;19(5):878\u201386.","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"5012_CR15","doi-asserted-by":"publisher","first-page":"F309","DOI":"10.1152\/ajprenal.00371.2021","volume":"322","author":"JC Oates","year":"2022","unstructured":"Oates JC, Russell DL, Van Beusecum JP. Endothelial cells: potential novel regulators of renal inflammation. Am J Physiol Ren Physiol. 2022;322(3):F309\u201321.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"3","key":"5012_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10157-013-0833-5","volume":"18","author":"N Shiraishi","year":"2014","unstructured":"Shiraishi N, Kitamura K, Kohda Y, Iseki K, Tomita K. Prevalence and risk factor analysis of nephrosclerosis and ischemic nephropathy in the Japanese general population. Clin Exp Nephrol. 2014;18(3):461\u20138.","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"5012_CR17","first-page":"126","volume":"16","author":"RE Tracy","year":"1996","unstructured":"Tracy RE. Renovasculopathies of hypertension and the rise of blood pressure with age in blacks and whites. Semin Nephrol. 1996;16(2):126\u201333.","journal-title":"Semin Nephrol"},{"issue":"11","key":"5012_CR18","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1093\/ndt\/11.11.2116","volume":"11","author":"A Meyrier","year":"1996","unstructured":"Meyrier A, Simon P. Nephroangiosclerosis and hypertension: things are not as simple as you might think. Nephrol Dial Transpl. 1996;11(11):2116\u201320.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"5012_CR19","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.kint.2020.08.024","volume":"99","author":"T Bardin","year":"2021","unstructured":"Bardin T, Nguyen QD, Tran KM, Le NH, Do MD, Richette P, et al. A cross-sectional study of 502 patients found a diffuse hyperechoic kidney medulla pattern in patients with severe gout. Kidney Int. 2021;99(1):218\u201326.","journal-title":"Kidney Int"},{"issue":"8","key":"5012_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4329\/wjr.v12.i8.184","volume":"12","author":"SH Barazani","year":"2020","unstructured":"Barazani SH, Chi WW, Pyzik R, Chang H, Jacobi A, O\u2019Donnell T, et al. Quantification of uric acid in vasculature of patients with gout using dual-energy computed tomography. World J Radiol. 2020;12(8):184\u201394.","journal-title":"World J Radiol"},{"issue":"6","key":"5012_CR21","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1161\/01.HYP.0000072820.07472.3B","volume":"41","author":"J Kanellis","year":"2003","unstructured":"Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41(6):1287\u201393.","journal-title":"Hypertension"},{"issue":"12","key":"5012_CR22","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1681\/ASN.2005050572","volume":"16","author":"DH Kang","year":"2005","unstructured":"Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16(12):3553\u201362.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"5012_CR23","doi-asserted-by":"publisher","first-page":"F991","DOI":"10.1152\/ajprenal.00283.2001","volume":"282","author":"M Mazzali","year":"2002","unstructured":"Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Ren Physiol. 2002;282(6):F991\u20137.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"4","key":"5012_CR24","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10157-012-0743-y","volume":"17","author":"K Suzuki","year":"2013","unstructured":"Suzuki K, Konta T, Kudo K, Sato H, Ikeda A, Ichikawa K, et al. The association between serum uric acid and renal damage in a community-based population: the Takahata study. Clin Exp Nephrol. 2013;17(4):541\u20138.","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"5012_CR25","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/S0272-6386(04)00934-5","volume":"44","author":"K Iseki","year":"2004","unstructured":"Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis. 2004;44(4):642\u201350.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"5012_CR26","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.semnephrol.2011.08.011","volume":"31","author":"DI Jalal","year":"2011","unstructured":"Jalal DI, Maahs DM, Hovind P, Nakagawa T. Uric acid as a mediator of diabetic nephropathy. Semin Nephrol. 2011;31(5):459\u201365.","journal-title":"Semin Nephrol"},{"issue":"8","key":"5012_CR27","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/hr.2014.75","volume":"37","author":"M Kuwabara","year":"2014","unstructured":"Kuwabara M, Niwa K, Nishi Y, Mizuno A, Asano T, Masuda K, et al. Relationship between serum uric acid levels and hypertension among Japanese individuals not treated for hyperuricemia and hypertension. Hypertens Res. 2014;37(8):785\u20139.","journal-title":"Hypertens Res"},{"issue":"5","key":"5012_CR28","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1161\/hy1101.092839","volume":"38","author":"M Mazzali","year":"2001","unstructured":"Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001;38(5):1101\u20136.","journal-title":"Hypertension"},{"issue":"12","key":"5012_CR29","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1097\/01.ASN.0000034910.58454.FD","volume":"13","author":"DH Kang","year":"2002","unstructured":"Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol. 2002;13(12):2888\u201397.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"5012_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/hr.2012.135","volume":"36","author":"K Kohagura","year":"2013","unstructured":"Kohagura K, Kochi M, Miyagi T, Kinjyo T, Maehara Y, Nagahama K, et al. An association between uric acid levels and renal arteriolopathy in chronic kidney disease: a biopsy-based study. Hypertens Res. 2013;36(1):43\u20139.","journal-title":"Hypertens Res"},{"issue":"6","key":"5012_CR31","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1053\/j.ajkd.2018.06.028","volume":"72","author":"K Kimura","year":"2018","unstructured":"Kimura K, Hosoya T, Uchida S, Inaba M, Makino H, Maruyama S, et al. Febuxostat therapy for patients with stage 3 CKD and asymptomatic hyperuricemia: a randomized trial. Am J Kidney Dis. 2018;72(6):798\u2013810.","journal-title":"Am J Kidney Dis"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05012-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05012-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05012-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T01:33:36Z","timestamp":1781573616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05012-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5012"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05012-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7890183\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"18 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adhered to the principles outlined in the Declaration of Helsinki. The study protocol was approved by the ethics committee of Nippon Medical School Tama-Nagayama Hospital (approval number 529, 2017). Informed consent to participate was obtained from all individuals involved in the study, and confidentiality was maintained throughout the research process. Information regarding this study was made public on the Tama City Medical Association\u2019s website, and the opportunity to refuse the use of medical information was guaranteed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests. Other co-authors declare that no conflict of interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"367"}}